ArticleInternational journal of general medicine2025
Diagnostic Value of Combined MRI and Ultrasound Features in Invasive Placenta Accreta and Prediction of Adverse Outcomes.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the diagnostic value of magnetic resonance imaging (MRI) combined with ultrasound features in invasive placenta accreta and to assess their effectiveness in predicting adverse clinical outcomes. Methods: A retrospective analysis was conducted on 173 pregnant women with suspected placenta accreta who were admitted to our hospital between March 2022 and May 2024. Surgical or pathological findings served as the diagnostic criteria. Patients were divided into an invasive placenta accreta group (n=104; including accreta and percreta) and a non-invasive group (n=69; including no placenta accreta or placenta adherent types). Baseline characteristics, MRI, and ultrasound features were compared between groups. Logistic regression was used to identify independent risk factors, and receiver operating characteristic (ROC) curves were applied to evaluate the diagnostic performance of MRI, ultrasound, and their combination. The invasive placenta accreta group was further classified into an adverse outcome subgroup (n=48; defined as intraoperative blood loss ≥1500 mL and/or hysterectomy) and a good outcome subgroup (n=56). The diagnostic value of imaging features for predicting adverse outcomes was analyzed. Results: Independent risk factors for invasive placenta accreta included myometrial thinning, low placental T2WI signal, blurred uteroplacental interface, abnormal placental vascular proliferation, localized bulging, loss of retroplacental space, moth-eaten placental changes, disrupted blood flow at the placental base, and ultrasound score (all P<0.05). The combined diagnosis achieved the highest diagnostic performance, with an AUC of 0.932 (95% CI: 0.876-0.965), sensitivity of 96.53%, and specificity of 91.91%, outperforming individual features. For predicting adverse outcomes, the combined model also demonstrated excellent accuracy, with an AUC of 0.941 (95% CI: 0.868-0.974), sensitivity of 93.06%, and specificity of 94.22%. Conclusion: MRI and ultrasound imaging features can be used independently or jointly in diagnosing invasive placenta accreta and predicting related adverse outcomes. The combined approach provides significantly better diagnostic accuracy and clinical value than either modality alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.